COVID-19 Vaccination: Myocarditis, Pericarditis and Coronary Heart Disease and Origin of the Disease

Shimon Shatzmiller

Department of Chemical Sciences, Ariel University, 40700 Ariel, Israel

Dr. Shimon Shatzmiller, Department of Chemical Sciences, Ariel University, 40700 Ariel, Israel.

Keywords: COVID-19; Vaccination; Coronary Heart Disease

Abstract

The Israeli Ministry of Health's extended epidemiological team that examined the relationship between the phenomenon and the vaccine included 3 professional teams: Team 1 - Public Health Experts from the Division of Epidemiology, Team 2 - Experts from the National Center for Disease Control and Team 3 - Experts from the Academy (Tel Aviv University, Haifa University and Technion). The three teams of experts performed an in-depth epidemiological examination and worked in combination, as part of the process of analyzing the disease follow-up data and findings. The teams' conclusion: There is a likelihood of linking the vaccine and the phenomenon among young men aged 30-16. The relationship is even stronger among 19- 16 year olds, relative to other ages. It also shows that the relationship weakens with increasing age. In most cases, it is a mild illness that passes within a few days.
Children who develop the rare complication after COVID-19 known as Multisystem [2] Inflammatory Syndrome in Children, or MIS-C, are at high risk for heart problems that may make it difficult for the heart to pump blood effectively for weeks after thought. After recovering, according to a new study by doctors at the Children's Hospital in Michigan.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).